Summit Therapeutics Inc.
SMMT
$18.95
$0.291.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 65.71% | 73.02% | -51.01% | -8.48% | 130.61% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 92.49% | -40.98% | 214.98% | 438.45% | 71.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -0.63% | -2.77% | -0.62% | -0.31% | 0.32% |
| Total Current Assets | 66.31% | 69.98% | -49.73% | -5.95% | 127.09% |
|
|
|||||
| Total Current Assets | 66.31% | 69.98% | -49.73% | -5.95% | 127.09% |
| Net Property, Plant & Equipment | 200.76% | 192.98% | -24.40% | -30.17% | -26.70% |
| Long-term Investments | 2.18% | 7.35% | 0.40% | 8.46% | 2.56% |
| Goodwill | 2.18% | 7.35% | 0.40% | 8.46% | 2.56% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 98.58% | 182.77% | 201.89% | 190.50% | 98.61% |
| Total Assets | 68.79% | 72.46% | -47.95% | -5.21% | 117.12% |
|
|
|||||
| Total Accounts Payable | 451.64% | 337.70% | 584.04% | 588.08% | -21.61% |
| Total Accrued Expenses | 100.89% | 49.14% | 43.76% | 1.26% | 103.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.27% | -10.01% | -90.39% | -96.99% | -4.22% |
| Total Finance Division Other Current Liabilities | 51.25% | 27.05% | 90.46% | 84.24% | -3.68% |
| Total Other Current Liabilities | 51.25% | 27.05% | 90.46% | 84.24% | -3.68% |
| Total Current Liabilities | 138.74% | 74.91% | 10.03% | -56.96% | 48.81% |
|
|
|||||
| Total Current Liabilities | 138.74% | 74.91% | 10.03% | -56.96% | 48.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 479.94% | 406.86% | -35.63% | -51.47% | -50.08% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.33% | 12.39% | 6.64% | 15.16% | -48.40% |
| Total Liabilities | 158.09% | 97.22% | 6.98% | -55.99% | -70.21% |
|
|
|||||
| Common Stock & APIC | 86.66% | 84.08% | 42.44% | 62.62% | 49.93% |
| Retained Earnings | -94.41% | -88.89% | -79.91% | -68.00% | -23.22% |
| Treasury Stock & Other | -2.69% | -11.16% | -17.37% | -10.12% | -4.65% |
| Total Common Equity | 58.55% | 69.48% | -56.10% | 32.99% | 678.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 58.55% | 69.48% | -56.10% | 32.99% | 678.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 58.55% | 69.48% | -56.10% | 32.99% | 678.85% |
|
|
|||||